Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vitamin K epoxide reductase expression and prostate cancer risk.

Urologic oncology - 1 Mar 2017

Tew Ben Yi, Pal Sumanta K, He Miaoling, Tong Tommy, Wu Huiqing, Hsu JoAnn, Liu Xueli, Neuhausen Susan L, Jones Jeremy O

Abstract excerpt

PURPOSE: Increasing evidence has demonstrated that men taking the anticoagulant warfarin have a lower risk of developing prostate cancer. This phenomenon is not observed in other cancers. We sought to determine if the target of warfarin, vitamin K epoxide reductase (VKOR), is expressed in benign and cancerous prostate tissues and if a functional single nucleotide polymorphism (SNP) in the VKOR gene is associated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Prostate
Share to Anticoagulants
Share to Biopsy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotyping Techniques

Share to Prostatectomy

Share to Tissue Array Analysis

Share to Vitamin K Epoxide Reductases

Share to Warfarin

Source

Identifiers

PMID: 27889279
DOI: 10.1016/j.urolonc.2016.10.020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Vitamin K epoxide reductase expression and prostate cancer risk.PMID 27889279Read ↗

MOLECULAR GENETIC PROFILING OF GLEASON GRADE 4/5 PROSTATE CANCERS COMPARED TO BENIGN PROSTATIC HYPERPLASIASemantic proximity Read ↗

Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia.Semantic proximity Read ↗

Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk.Semantic proximity Read ↗

Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer.Semantic proximity Read ↗

The association between estrogen receptor alpha polymorphisms and the risk of prostate cancer in Slovak population.Semantic proximity Read ↗

TRPV6 alleles do not influence prostate cancer progression.Semantic proximity Read ↗

Relative concentrations of hK2/PSA mRNA in benign and malignant prostatic tissueSemantic proximity Read ↗

Association between estrogen receptor alpha PvuII polymorphism and prostate cancer risk.Semantic proximity Read ↗

Warfarin pharmacogenes do not modify the risk association between warfarin use and cancer mortality among men with prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.